Fig. 5: Correlation of BIRC5 with miR-195 expression and patient survival in LUAD.
From: miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
a Expression of BIRC5 is higher in tumor tissues than in adjacent normal tissues in 55 out of 57 LUAD patients. b Correlation of miR-195 expression with BIRC5 expression in tumor tissues of LUAD patients (n = 467). c Overall survival curves for LUAD patients based on BIRC5 expression in tumor tissues. d Overall survival curves for LUAD patients based on the ratio of miR-195 to BIRC5 expression in tumor tissues. e Recurrence-free survival curves for LUAD patients based on miR-195 expression in tumor tissues. f Recurrence-free survival curves for LUAD patients based on BIRC5 expression in tumor tissues. g Recurrence-free survival curves for LUAD patients based on the ratio of miR-195 to BIRC5 expression in tumor tissues
